Sapiens (SPNS) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

SPNS Stock Forecast


Sapiens stock forecast is as follows: an average price target of $38.00 (represents a 2.01% upside from SPNS’s last price of $37.25) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.

SPNS Price Target


The average price target for Sapiens (SPNS) is $38.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $38.00 to $38.00. This represents a potential 2.01% upside from SPNS's last price of $37.25.

SPNS Analyst Ratings


Buy

According to 4 Wall Street analysts, Sapiens's rating consensus is 'Buy'. The analyst rating breakdown for SPNS stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 0 'Hold' (0.00%), 2 'Sell' (50.00%), and 0 'Strong Sell' (0.00%).

Sapiens Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 02, 2024Tavy RosnerBarclays$38.00$36.145.15%2.01%
Row per page
Go to

The latest Sapiens stock forecast, released on Aug 02, 2024 by Tavy Rosner from Barclays, set a price target of $38.00, which represents a 5.15% increase from the stock price at the time of the forecast ($36.14), and a 2.01% increase from SPNS last price ($37.25).

Sapiens Price Target by Period


1M3M12M
# Anlaysts--1
Avg Price Target--$38.00
Last Closing Price$37.25$37.25$37.25
Upside/Downside-100.00%-100.00%2.01%

In the current month, the average price target of Sapiens stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sapiens's last price of $37.25. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Aug 02, 2024BarclaysUnderweightUnderweightHold
Apr 26, 2022Zacks Investment Research-SellDowngrade
Feb 24, 2022CitigroupBuyBuyHold
Feb 24, 2022NeedhamBuyBuyHold
Row per page
Go to

Sapiens's last stock rating was published by Barclays on Aug 02, 2024. The company gave SPNS a "Underweight" rating, the same as its previous rate.

Sapiens Financial Forecast


Sapiens Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
Revenue-----------$124.72M$119.46M$119.00M$118.58M$117.69M$119.22M$117.81M$114.41M$109.59M$101.66M$97.64M$93.06M$90.53M$86.72M$82.64M$79.53M$76.79M$71.08M$56.53M
Avg Forecast$151.50M$150.60M$147.10M$144.30M$141.53M$140.38M$137.78M$133.72M$130.85M$130.01M$126.56M$121.96M$120.86M$120.83M$123.25M$117.21M$120.58M$117.78M$112.50M$109.83M$100.56M$96.85M$91.10M$88.03M$85.14M$81.74M$78.64M$75.69M$54.62M$226.12M
High Forecast$151.50M$150.60M$147.10M$144.30M$141.53M$140.55M$137.78M$133.72M$132.22M$131.04M$126.56M$121.96M$120.86M$120.83M$123.25M$117.21M$120.58M$117.78M$112.50M$109.83M$100.56M$96.85M$91.10M$88.03M$85.14M$81.74M$78.64M$75.69M$65.54M$271.34M
Low Forecast$151.50M$150.60M$147.10M$144.30M$141.53M$140.23M$137.78M$133.72M$129.80M$129.24M$126.56M$121.96M$120.86M$120.83M$123.25M$117.21M$120.58M$117.78M$112.50M$109.83M$100.56M$96.85M$91.10M$88.03M$85.14M$81.74M$78.64M$75.69M$43.69M$180.90M
# Analysts11112421363344443333316811711771719
Surprise %-----------1.02%0.99%0.98%0.96%1.00%0.99%1.00%1.02%1.00%1.01%1.01%1.02%1.03%1.02%1.01%1.01%1.01%1.30%0.25%

Sapiens's average Quarter revenue forecast for Jun 23 based on 3 analysts is $126.56M, with a low forecast of $126.56M, and a high forecast of $126.56M. SPNS's average Quarter revenue forecast represents a 1.47% increase compared to the company's last Quarter revenue of $124.72M (Mar 23).

Sapiens EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts11112421363344443333316811711771719
EBITDA-----------$24.30M$16.48M$22.20M$22.02M$22.43M$24.01M$23.14M$20.04M$19.13M$15.90M$16.64M$13.38M$18.28M$3.84M$18.10M$13.65M$15.28M$13.20M$1.11M
Avg Forecast$29.25M$29.07M$28.40M$27.86M$27.32M$27.10M$26.60M$25.46M$25.26M$25.10M$24.43M$23.14M$24.65M$23.33M$23.79M$21.04M$23.28M$22.74M$21.72M$19.13M$19.41M$18.70M$17.59M$17.32M$16.44M$15.78M$15.18M$13.24M$9.24M$1.74M
High Forecast$29.25M$29.07M$28.40M$27.86M$27.32M$27.13M$26.60M$30.55M$25.53M$25.30M$24.43M$27.77M$29.58M$23.33M$23.79M$25.25M$23.28M$22.74M$21.72M$22.95M$19.41M$18.70M$17.59M$20.78M$16.44M$15.78M$15.18M$15.89M$11.09M$2.09M
Low Forecast$29.25M$29.07M$28.40M$27.86M$27.32M$27.07M$26.60M$20.37M$25.06M$24.95M$24.43M$18.51M$19.72M$23.33M$23.79M$16.83M$23.28M$22.74M$21.72M$15.30M$19.41M$18.70M$17.59M$13.86M$16.44M$15.78M$15.18M$10.59M$7.39M$1.39M
Surprise %-----------1.05%0.67%0.95%0.93%1.07%1.03%1.02%0.92%1.00%0.82%0.89%0.76%1.06%0.23%1.15%0.90%1.15%1.43%0.63%

3 analysts predict SPNS's average Quarter EBITDA for Jun 23 to be $24.43M, with a high of $24.43M and a low of $24.43M. This is 0.53% upper than Sapiens's previous annual EBITDA (Mar 23) of $24.30M.

Sapiens Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts11112421363344443333316811711771719
Net Income-----------$14.20M$13.37M$13.39M$11.91M$13.93M$13.64M$13.27M$10.40M$9.84M$8.32M$9.34M$5.71M$10.41M$-1.99M$10.41M$6.84M$8.39M$6.31M$-2.24M
Avg Forecast$22.89M$22.47M$22.04M$21.06M$21.23M$21.12M$20.31M$13.09M$19.04M$18.81M$18.11M$11.90M$14.03M$16.57M$16.59M$10.82M$16.64M$16.24M$14.78M$9.84M$14.27M$13.01M$11.57M$9.86M$11.34M$10.45M$9.44M$7.27M$4.41M$-3.48M
High Forecast$22.89M$22.47M$22.04M$21.06M$21.23M$22.26M$20.32M$15.71M$19.60M$19.37M$18.11M$14.28M$16.84M$16.57M$16.59M$12.98M$16.64M$16.24M$14.78M$11.80M$14.27M$13.01M$11.57M$11.84M$11.34M$10.45M$9.44M$8.73M$5.30M$-2.79M
Low Forecast$22.89M$22.47M$22.04M$21.06M$21.23M$20.55M$20.30M$10.47M$18.48M$18.26M$18.11M$9.52M$11.22M$16.57M$16.59M$8.65M$16.64M$16.24M$14.78M$7.87M$14.27M$13.01M$11.57M$7.89M$11.34M$10.45M$9.44M$5.82M$3.53M$-4.18M
Surprise %-----------1.19%0.95%0.81%0.72%1.29%0.82%0.82%0.70%1.00%0.58%0.72%0.49%1.06%-0.18%1.00%0.72%1.15%1.43%0.64%

Sapiens's average Quarter net income forecast for Jun 23 is $18.11M, with a range of $18.11M to $18.11M. SPNS's average Quarter net income forecast represents a 27.59% increase compared to the company's last Quarter net income of $14.20M (Mar 23).

Sapiens SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts11112421363344443333316811711771719
SG&A-----------$18.52M$18.57M$18.92M$18.80M$18.72M$19.04M$18.32M$20.18M$18.80M$20.02M$17.61M$18.77M$13.21M$19.17M$12.20M$13.08M$11.19M$11.10M$14.59M
Avg Forecast$24.00M$23.86M$23.30M$22.86M$22.42M$22.24M$21.83M$25.03M$20.73M$20.60M$20.05M$22.75M$19.55M$19.14M$19.52M$20.68M$19.10M$18.66M$17.82M$18.80M$15.93M$15.34M$14.43M$12.52M$13.49M$12.95M$12.46M$9.69M$7.77M$22.98M
High Forecast$24.00M$23.86M$23.30M$22.86M$22.42M$22.26M$21.83M$30.03M$20.95M$20.76M$20.05M$27.30M$23.46M$19.14M$19.52M$24.82M$19.10M$18.66M$17.82M$22.56M$15.93M$15.34M$14.43M$15.02M$13.49M$12.95M$12.46M$11.63M$9.32M$27.57M
Low Forecast$24.00M$23.86M$23.30M$22.86M$22.42M$22.22M$21.83M$20.02M$20.56M$20.47M$20.05M$18.20M$15.64M$19.14M$19.52M$16.55M$19.10M$18.66M$17.82M$15.04M$15.93M$15.34M$14.43M$10.01M$13.49M$12.95M$12.46M$7.75M$6.21M$18.38M
Surprise %-----------0.81%0.95%0.99%0.96%0.91%1.00%0.98%1.13%1.00%1.26%1.15%1.30%1.06%1.42%0.94%1.05%1.15%1.43%0.63%

Sapiens's average Quarter SG&A projection for Jun 23 is $20.05M, based on 3 Wall Street analysts, with a range of $20.05M to $20.05M. The forecast indicates a 8.26% rise compared to SPNS last annual SG&A of $18.52M (Mar 23).

Sapiens EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Mar 18Mar 17
# Analysts11112421363344443333316811711771719
EPS-----------$0.26$0.24$0.25$0.22$0.25$0.25$0.24$0.19$0.18$0.16$0.19$0.11$0.21$-0.04$0.21$0.14$0.17$0.13$-0.05
Avg Forecast$0.41$0.40$0.39$0.38$0.38$0.38$0.36$0.34$0.34$0.34$0.32$0.31$0.31$0.29$0.30$0.27$0.30$0.29$0.26$0.27$0.25$0.23$0.21$0.19$0.20$0.19$0.17$0.15$0.07$0.13
High Forecast$0.41$0.40$0.39$0.38$0.38$0.40$0.36$0.34$0.35$0.34$0.32$0.31$0.31$0.29$0.30$0.27$0.30$0.29$0.26$0.27$0.25$0.23$0.21$0.19$0.20$0.19$0.17$0.15$0.08$0.15
Low Forecast$0.41$0.40$0.39$0.38$0.38$0.37$0.36$0.34$0.33$0.33$0.32$0.31$0.31$0.29$0.30$0.27$0.30$0.29$0.26$0.27$0.25$0.23$0.21$0.19$0.20$0.19$0.17$0.15$0.06$0.10
Surprise %-----------0.84%0.78%0.85%0.74%0.93%0.84%0.83%0.72%0.67%0.63%0.82%0.53%1.09%-0.20%1.13%0.83%1.12%1.86%-0.35%

According to 3 Wall Street analysts, Sapiens's projected average Quarter EPS for Jun 23 is $0.32, with a low estimate of $0.32 and a high estimate of $0.32. This represents a 24.04% increase compared to SPNS previous annual EPS of $0.26 (Mar 23).

Sapiens Peer Comparison by Price Target


TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
PROPROS$20.73$32.6757.60%Buy
PDFSPDF Solutions$28.69$43.5051.62%-
ETWOE2open Parent$2.94$4.4049.66%Hold
AMSWAAmerican Software$10.95$15.5041.55%Buy
PYCRPaycor HCM$15.71$22.0040.04%Hold
APPFAppFolio$212.00$278.0031.13%Buy
AGYSAgilysys$102.95$116.2012.87%Buy
PRGSProgress Software$63.94$70.209.79%Buy
MANHManhattan Associates$266.64$276.573.72%Buy
SPNSSapiens$37.25$38.002.01%Buy
GWREGuidewire Software$185.52$164.70-11.22%Buy
MLNKMeridianLink$23.09$20.00-13.38%Buy

SPNS Forecast FAQ


Yes, according to 4 Wall Street analysts, Sapiens (SPNS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of SPNS's total ratings.

Sapiens (SPNS) average price target is $38 with a range of $38 to $38, implying a 2.01% from its last price of $37.25. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

According to Wall Street analysts' prediction for SPNS stock, the company can go up by 2.01% (from the last price of $37.25 to the average price target of $38), up by 2.01% based on the highest stock price target, and up by 2.01% based on the lowest stock price target.

SPNS's average twelve months analyst stock price target of $38 does not support the claim that Sapiens can reach $60 in the near future.

Sapiens's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $553.41M (high $553.59M, low $553.27M), average EBITDA is $106.48M (high $111.6M, low $101.36M), average net income is $75.75M (high $79.52M, low $72.55M), average SG&A $91.51M (high $96.55M, low $86.49M), and average EPS is $1.46 (high $1.48, low $1.45). SPNS's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $593.5M (high $593.5M, low $593.5M), average EBITDA is $114.58M (high $114.58M, low $114.58M), average net income is $88.46M (high $88.46M, low $88.46M), average SG&A $94.02M (high $94.02M, low $94.02M), and average EPS is $1.57 (high $1.57, low $1.57).

Based on Sapiens's last annual report (Dec 2022), the company's revenue was $474.74M, which missed the average analysts forecast of $482.15M by -1.54%. Apple's EBITDA was $88.73M, missing the average prediction of $92.81M by -4.39%. The company's net income was $52.6M, missing the average estimation of $58.01M by -9.33%. Apple's SG&A was $75.02M, missing the average forecast of $78.9M by -4.92%. Lastly, the company's EPS was $0.96, missing the average prediction of $1.17 by -17.69%. In terms of the last quarterly report (Mar 2023), Sapiens's revenue was $124.72M, beating the average analysts' forecast of $121.96M by 2.27%. The company's EBITDA was $24.3M, beating the average prediction of $23.14M by 5.01%. Sapiens's net income was $14.2M, beating the average estimation of $11.9M by 19.29%. The company's SG&A was $18.52M, missing the average forecast of $22.75M by -18.60%. Lastly, the company's EPS was $0.26, missing the average prediction of $0.31 by -16.13%